Literature DB >> 28189175

Autoimmune Hemolytic Anemia.

Howard A Liebman1, Ilene C Weitz2.   

Abstract

Autoimmune hemolytic anemia is an acquired autoimmune disorder resulting in the production of antibodies directed against red blood cell antigens causing shortened erythrocyte survival. The disorders can present as a primary disorder (idiopathic) or secondary to other autoimmune disorders, malignancies, or infections. Treatment involves immune modulation with corticosteroids and other agents.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anemia; Autoantibodies; Hemolysis

Mesh：

Substances：

Year:  2016        PMID： 28189175     DOI： 10.1016/j.mcna.2016.09.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  19 in total

1.  Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.

Authors:  Gael F P Bories; Scott Yeudall; Vlad Serbulea; Todd E Fox; Brant E Isakson; Norbert Leitinger
Journal:  Blood       Date:  2020-09-24       Impact factor: 22.113

2.  Autoimmune haemolytic anaemia in pancreatic adenocarcinoma: a potential paraneoplastic presentation.

Authors:  Anis Hariz; Mohamed Salah Hamdi; Imen Boukhris; Eya Cherif
Journal:  BMJ Case Rep       Date:  2019-07-15

3.  A Rare Case of COVID-19 Associated With Autoimmune Hemolytic Anemia, Thrombocytopenia and Acute Kidney Injury.

Authors:  Muzamil Musa; El Mustafa Abdalla; Maab F Elhaj; Salma Mustafa; Sharif A Ahmed; Jamal Sajid
Journal:  Cureus       Date:  2022-06-16

Review 4.  Hemolytic anemia in COVID-19.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Ajeet Kaushik; Małgorzata Kujawska; Gaber El-Saber Batiha
Journal:  Ann Hematol       Date:  2022-07-08       Impact factor: 4.030

Review 5.  Haemolysis index for the screening of intravascular haemolysis: a novel diagnostic opportunity?

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  Blood Transfus       Date:  2018-05-08       Impact factor: 3.443

6.  A Case of COVID-19-Associated Autoimmune Hemolytic Anemia With Hyperferritinemia in an Immunocompetent Host.

Authors:  Zoha Huda; Abdullah Jahangir; Syeda Sahra; Muhammad Rafay Khan Niazi; Shamsuddin Anwar; Allison Glaser; Ahmad Jahangir
Journal:  Cureus       Date:  2021-06-30

7.  Successful treatment of acute-on-chronic liver failure and hemolytic anemia with hepato-protective drugs in combination with intravenous ozone without steroids: A case report.

Authors:  Zhaohui Bai; Hongyu Li; Xiaozhong Guo; Yanqin Liu; Jiao Deng; Chunhui Wang; Yingying Li; Xingshun Qi
Journal:  Intractable Rare Dis Res       Date:  2018-08

Review 8.  Tuberculosis induced autoimmune haemolytic anaemia: a systematic review to find out common clinical presentations, investigation findings and the treatment options.

Authors:  Devarajan Rathish; Sisira Siribaddana
Journal:  Allergy Asthma Clin Immunol       Date:  2018-03-26       Impact factor: 3.406

9.  Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab.

Authors:  Xiaofan Li; Jiafu Huang; Zhijuan Zhu; Nainong Li
Journal:  J Int Med Res       Date:  2019-07-07       Impact factor: 1.671

10.  Legionella-Induced Autoimmune Hemolytic Anemia: A Delayed and Unexpected Complication.

Authors:  Richard Jesse Durrance; Fabiano Das Gracas; Shetra Sivamurthy; Bhupinder B Singh
Journal:  J Hematol (Brossard)       Date:  2019-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.